antibody

Evusheld

Pharma

FDA warns AZ's Evusheld is less effective against new subvariant

The FDA has updated its fact sheet for AstraZeneca's Evusheld, saying it can increase the risk of COVID infection for some subvariants of omicron.

Kevin Dunleavy Oct 4, 2022 11:15am

FDA

GSK, Vir's COVID antibody put on ice as BA.2 variant takes hold

Apr 5, 2022 3:42pm